Metastatic pathways in patients with cutaneous melanoma.
about
Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis.Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.PAX3d mRNA over 2.76 copies/µL in the bloodstream predicts cutaneous malignant melanoma relapse.MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.
P2860
Metastatic pathways in patients with cutaneous melanoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metastatic pathways in patients with cutaneous melanoma.
@en
Metastatic pathways in patients with cutaneous melanoma.
@nl
type
label
Metastatic pathways in patients with cutaneous melanoma.
@en
Metastatic pathways in patients with cutaneous melanoma.
@nl
prefLabel
Metastatic pathways in patients with cutaneous melanoma.
@en
Metastatic pathways in patients with cutaneous melanoma.
@nl
P2093
P2860
P356
P1476
Metastatic pathways in patients with cutaneous melanoma.
@en
P2093
Andrew Haydon
John W Kelly
Nikki R Adler
Victoria J Mar
P2860
P356
10.1111/PCMR.12544
P50
P577
2016-10-19T00:00:00Z